Lakefront Biotherapeutics (LKFT) Intangibles (2013 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Intangibles for 13 consecutive years, with $873376.3 the latest figure, recorded in Q1 2026.

• In Q1 2026, Intangibles fell 99.47% year-over-year to $873376.3; the TTM figure through Mar 2026 stood at $873376.3 (down 99.47% YoY), while the FY2025 annual figure was $987108.9, down 99.44% from the prior year.
• Intangibles slipped to $873376.3 in Q1 2026 per LKFT's latest filing, from $987108.9 in the prior quarter.
• Across five years, Intangibles topped out at $190.5 million in Q3 2024 and bottomed at $873376.3 in Q1 2026.
• Historically, Intangibles has averaged $121.2 million across 5 years, with a median of $151.2 million in 2023.
• Annual changes were most pronounced in 2022 — Intangibles surged 162.26% — and 2026, when it sank 99.47%.
• Lakefront Biotherapeutics' Intangibles stood at $180.3 million in 2022, then gained by 4.59% to $188.6 million in 2023, then retreated by 6.59% to $176.2 million in 2024, then tumbled by 99.44% to $987108.9 in 2025, then slipped by 11.52% to $873376.3 in 2026.
• Business Quant data shows LKFT's Intangibles at $873376.3 in Q1 2026, $987108.9 in Q4 2025, and $8.7 million in Q3 2025.